RiverVest Venture Fund IV, L.P.

Insider Reports History

Entity
Company
Location
101 South Hanley Road, Suite 1850, St. Louis, MO
Signature
/s/ Jay Schmelter, Manager of RiverVest Venture Partners IV, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RiverVest Venture Fund IV, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1.44M $1.2M $0.83 Oct 26, 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Oct 26, 2021 Indirect

Insider Reports Filed by RiverVest Venture Fund IV, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Oct 26, 2021 5 $4M 4 Oct 26, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner